The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Lithium Carbonate
Lithium Carbonate · LITHIUM CARBONATE 300 mg/1 · Tablet, Extended Release · Oral · PD-Rx Pharmaceuticals, Inc.
NDC 72789-0171-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$47.72
Reported to Texas DSHS · 2025 annual filing · PD_Rx Pharmaceuticals, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for lithium carbonate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- PD-Rx Pharmaceuticals Inc.United Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA076832
- TE code
- AB
- Approval date
- Oct 28, 2004
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Lithium Carbonate (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| PD-Rx Pharmaceuticals, Inc. | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | LITHIUM CARBONATE 450 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LITHIUM CARBONATE 450 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | LITHIUM CARBONATE 450 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | LITHIUM CARBONATE 450 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | LITHIUM CARBONATE 450 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Remedyrepack Inc. | LITHIUM CARBONATE 300 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Lithium Carbonate — NDC 72789-0171-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72789017101.
Free to cite with attribution — see how the data is put together.